Gaëtan Ligat

12PUBLICATIONS
25CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Haematological tumoursMedical molecular engineering of nucleic acids and proteinsPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 31, 2025
Targeting Human Cytomegalovirus as a Novel Approach for Glioblastoma Treatment.

Thelma Flores, Eloïse Delpierre, Ghislain Male

|Aug 21, 2025
Toxoplasma gondii infection and chronic IL-1 elevation drive hippocampal DNA double-strand break signaling, leading to cognitive deficits.

Marcy Belloy, Benjamin A M Schmitt, Florent H Marty

|Jan 02, 2023
Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target.

Eloi R Verrier, Gaëtan Ligat, Laura Heydmann

|Mar 10, 2022
Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives.

Valerio Taverniti, Gaëtan Ligat, Yannick Debing

|Sep 28, 2021
Towards a Prophylactic Vaccine for the Prevention of HCMV Infection.

Gaëtan Ligat, Sophie Alain, Sébastien Hantz

|Aug 28, 2021
New Insights into Human Cytomegalovirus pUL52 Structure.

Clotilde Muller, Sophie Alain, Claire Gourin

Pageof 2

Frequent Collaborators

5 joint publications

Sébastien Hantz

4 joint publications

Thomas F Baumert

2 joint publications

Clotilde Muller

2 joint publications

Claire Gourin